Abstract
IDA affects greater than one in 10 Australian pregnant women and has been associated with a range of adverse maternal and infant health outcomes.3 Despite its high prevalence, there has been a significant lack of research pertaining to its optimal identification and subsequent management. This was highlighted in a recent editorial by Seeho and Morris,4 who expressed a number of clinical practice concerns including routine iron supplementation in pregnancy, increased utilisation of ferritin to screen all women for iron deficiency, and the rapidly increasing utilisation of intravenous iron.
Original language | English |
---|---|
Pages (from-to) | E32-E33 |
Number of pages | 2 |
Journal | Australian and New Zealand Journal of Obstetrics and Gynaecology |
Volume | 58 |
Issue number | 6 |
DOIs | |
Publication status | Published - 10 Dec 2018 |
Keywords
- iron‐deficiency anaemia (IDA)
- iron supplementation
- pregnancy